Complex karyotypic abnormalities in MYC, the activation of NRAS and KRAS, mutations in TP53, and inactivation of CDKN2A and CDKN2C are late-onset translocations and gene mutations that promote a higher rate of progression to MM [12,13]. The gene discussed is NRAS; the disease is Miyoshi myopathy.